Encompass Health Co. (NYSE:EHC) EVP John Patrick Darby Sells 14,543 Shares of Stock

Encompass Health Co. (NYSE:EHC) EVP John Patrick Darby sold 14,543 shares of the company’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $83.94, for a total transaction of $1,220,739.42. Following the sale, the executive vice president now directly owns 84,773 shares of the company’s stock, valued at $7,115,845.62. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Encompass Health Stock Up 1.7 %

Encompass Health stock opened at $85.93 on Wednesday. The company’s 50-day moving average price is $79.33 and its two-hundred day moving average price is $71.79. The stock has a market cap of $8.65 billion, a price-to-earnings ratio of 23.22, a PEG ratio of 1.30 and a beta of 0.92. Encompass Health Co. has a 52 week low of $57.55 and a 52 week high of $86.60. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 1.14.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, April 24th. The company reported $1.12 EPS for the quarter, topping the consensus estimate of $0.93 by $0.19. The firm had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.27 billion. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The firm’s quarterly revenue was up 13.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.88 earnings per share. On average, analysts expect that Encompass Health Co. will post 4.1 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Investors of record on Monday, July 1st will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date is Friday, June 28th. Encompass Health’s payout ratio is currently 16.22%.

Analyst Upgrades and Downgrades

EHC has been the topic of a number of analyst reports. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Stephens restated an “overweight” rating and set a $85.00 price objective on shares of Encompass Health in a research report on Tuesday, January 16th. Truist Financial increased their target price on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Royal Bank of Canada reissued an “outperform” rating and set a $83.00 price target on shares of Encompass Health in a report on Friday, February 9th. Finally, Barclays boosted their target price on shares of Encompass Health from $101.00 to $108.00 and gave the company an “overweight” rating in a research note on Thursday, April 25th. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Encompass Health currently has an average rating of “Buy” and an average target price of $90.29.

Institutional Investors Weigh In On Encompass Health

Several hedge funds and other institutional investors have recently bought and sold shares of the business. TD Asset Management Inc grew its stake in shares of Encompass Health by 239.6% in the 4th quarter. TD Asset Management Inc now owns 1,969,186 shares of the company’s stock worth $131,384,000 after purchasing an additional 1,389,275 shares during the last quarter. 8 Knots Management LLC bought a new stake in shares of Encompass Health during the 4th quarter worth $75,424,000. Norges Bank acquired a new position in shares of Encompass Health in the 4th quarter worth $69,178,000. Invesco Ltd. raised its position in shares of Encompass Health by 22.3% during the third quarter. Invesco Ltd. now owns 3,974,306 shares of the company’s stock worth $266,914,000 after purchasing an additional 724,544 shares during the period. Finally, Epoch Investment Partners Inc. boosted its position in shares of Encompass Health by 102.9% in the 4th quarter. Epoch Investment Partners Inc. now owns 1,399,341 shares of the company’s stock valued at $93,364,000 after purchasing an additional 709,593 shares during the period. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.